Preparation method of pseudo-ginseng dysmenorrhea dispersible tablets
A technology for dispersible tablets and dysmenorrhea, which is applied in the field of preparation of dispersible tablets for dysmenorrhea drugs, can solve the problems of slow disintegration, poor compliance, and low bioavailability, and achieve good stability, low cost, and high bioavailability of the preparation Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
specific Embodiment approach 1
[0016] Specific embodiment one: the preparation method of a kind of Tianqitongjing dispersible tablet of the present embodiment is carried out according to the following steps:
[0017] 1. Weigh 50 to 100 parts of Tian Qi, 1000 to 2000 parts of ethanol solution with a volume concentration of 70% to 75%, 50 to 100 parts of Wulingzhi, and 30 to 60 parts of Puhuang according to the ratio of parts by mass , 50-100 parts of Yanhusuo, 50-100 parts of Chuanxiong, 50-100 parts of fennel, 30-60 parts of woody fragrance, 3000-6000 parts of deionized water, 2-6 parts of borneol, 180-300 parts 100-200 parts of microcrystalline cellulose, 100-200 parts of mannitol, 20-40 parts of crospovidone and 4-6 parts of magnesium stearate;
[0018] 2. Take 900-1500 parts of Hetianqi from the ethanol solution weighed in step 1, mix them, soak them for 0.5-1 hour, decoct them for 2-4 times, filter, combine the decoction liquid, and then put them at a temperature of 60-80℃ The decoction is concentrated...
specific Embodiment approach 2
[0027]Specific embodiment two: the difference between this embodiment and specific embodiment one is: in step 1, the volume concentration of 60 parts of Tianqi, 1080 parts by weight is 75% ethanol solution, 60 parts of Wuling butter, 40 parts of Puhuang, 60 parts of Yanhusuo, 60 parts of Chuanxiong, 60 parts of fennel, 40 parts of woody fragrance, 5440 parts of deionized water, 4 parts of borneol, 200 parts of microcrystalline cellulose, 167 parts of mannitol, 16 parts of crospovidone and 5 parts of magnesium stearate. Others are the same as in the first embodiment.
specific Embodiment approach 3
[0028] Specific embodiment 3: The difference between this embodiment and specific embodiment 1 or 2 is that in step 2, at a temperature of 70°C, the decoction is concentrated to a relative density of 110 g / cm 3 . Others are the same as in the first or second embodiment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com